QURE uniQure N.V.
$24.28▲ +12.15%
Healthcare
Other
After hours
$24.96▲ +2.80%
Oct 27, 5:31 PM ET
Volume 1.57M
Avg Volume (10D) 1.60M
Key Metrics & Fundamentals
Market Cap
$1.68B
P/E Ratio
–
Div Yield
0.00%
52W Range
8.73 - 71.50
% vs 50 MA
-32.47%
% vs 200 MA
-18.01%
RSI-14
39.7
MACD Histogram
+0.9100
Beta (1Y vs SPY)
0.33
Free Cash Flow
-$29.05M
Gross Rev
$5.84M
Gross Profit
$5.49M
EBITDA
-$58.22M
COGS
$350,000
Operating Exp
$50.17M
Operating Income
-$44.68M
EBIT
-$44.68M
Pretax Income
-$79.22M
Net Income
-$81.06M
EPS (Diluted)
-1.22
Price & Volume History
Loading chart…
Recent News
UBS Adjusts Price Target on uniQure to $48 From $27, Maintains Buy Rating
MT Newswires · Oct 15, 2026 10:51 AM ET
Why uniQure (QURE) Is Down 5.9% After Fresh Huntington’s Gene Therapy Data Update And What’s Next
Simply Wall St. · Oct 7, 2026 9:09 AM ET
UniQure Shares Fall After Barclays Downgrade
MT Newswires · Oct 5, 2026 3:40 PM ET
Barclays Downgrades uniQure to Equal Weight From Overweight
MT Newswires · Oct 5, 2026 7:45 AM ET
RBC Cuts Price Target on uniQure to $48 From $65, Keeps Outperform, Speculative Risk
MT Newswires · Oct 2, 2026 7:42 AM ET
uniQure (QURE) Faces A Fresh AMT 130 Test After Mixed Data, Bargain Or Trap
Simply Wall St. · Oct 1, 2026 1:09 AM ET
uniQure Plunges on Additional Data From Huntington's Disease Study
Zacks · Sep 30, 2026 12:47 PM ET
uniQure Stock Crashed on Its Huntington’s Data. Wall Street’s Price Target Says the Selloff Went Too Far
24/7 Wall St. · Sep 30, 2026 11:48 AM ET
QURE Stock Clocks Worst Day In Over 10 Months: Four-Year Huntington’s Data Spooks Investors Despite Stronger Three-Year Filing Data
Stocktwits · Sep 29, 2026 6:08 PM ET
Uniqure Plummets 37% On Another Shocking Twist For Its Huntington's Drug
Investor's Business Daily · Sep 29, 2026 4:56 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See QURE's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.